Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This systematic review examined the reliability and validity of the Morisky Medication Adherence Scale-8 (MMAS-8), which has been widely used to assess patient medication adherence in clinical research and medical practice. METHODS: Of 418 studies identified through searching 4 electronic databases, we finally analyzed 28 studies meeting the selection criteria of this study regarding the reliability and validity of MMAS-8 including sensitivity and specificity. Meta-analysis for Cronbach's α, intraclass correlation coefficient (ICC), sensitivity and specificity to detect a patient with nonadherence to medication were performed. The pooled estimates for Cronbach's α and ICC were calculated using the random-effects weighted T transformation. A bivariate random-effects model was used to estimate pooled sensitivity and specificity. FINDINGS: The pooled Cronbach's α estimate for type 2 diabetes group in 7 studies and osteoporosis group in 3 studies were 0.67 (95% Confidence Interval(CI), 0.65 to 0.69) and 0.77 (95% CI, 0.72 to 0.83), respectively. With regard to test-retest, the pooled ICC for type 2 diabetes group in 3 studies and osteoporosis group in 2 studies were 0.81 (95% CI, 0.75 to 0.85) and 0.80 (95% CI, 0.74 to 0.85). For a cut-off value of 6, the pooled sensitivity and specificity in 12 studies were 0.43 (95% CI, 0.33 to 0.53) and 0.73 (95% CI, 0.68 to 0.78), respectively. CONCLUSIONS: The MMAS-8 had acceptable internal consistency and reproducibility in a few diseases like type 2 diabetes. Using the cut-off value of 6, criterion validity was not enough good to validly screen a patient with nonadherence to medication. However, this study did not calculated a pooled estimate for criterion validity using the higher values than 6 as a cut-off value since most of included individual studies did not report criterion validity based on those values.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The PHQ-8, MMAS, and the AAQ2 are widely used, with adequate reliability and validity (Bond et al., 2011; Moon et al., 2017; Villarreal-Zegarra et al., 2023).”
From Work-Related Cognitive Behavioral Therapy for racially and economically diverse unemployed persons with social anxiety: A randomized clinical trial (2024) · cites this paper as Moon et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 14×
“Validation: Weon-Young Lee, Jin Seub Hwang, Donald E. Morisky.”
BackgroundMethodInfluentialSelf-citationRetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317 · cited 1×
“developed a self-reported scale with 4 items regarding common medicationtaking behaviours leading to omission of drug [12].”
BackgroundSelf-citationKirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369 · cited 1×
“Parameter estimates of this model are the summary receiver operating characteristics (SROC) curve, the summary operating point (summary values for sensitivity and specificity), a 95% confidence region around the summary operating point and a 95% prediction region based the cut-off 6 of common threshold [33].”
MethodOn the use, the misuse, and the very limited usefulness of Cronbach’s alpha
Sijtsma, K. (2009) · Psychometrika · doi:10.1007/s11336-008-9101-0 · Cited by 2,814
Medication Adherence: WHO Cares?
Brown, M. T., & Bussell, J. K. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0575 · Cited by 1,928 · cited 1×
“In this regard, the disadvantaged people with chronic diseases are especially vulnerable to poor adherence to medication due to lack of resources [3, 4].”
BackgroundJones, C. M., & Athanasiou, T. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.09.040 · Cited by 523 · cited 2×
“The SROC graph is conceptually very similar to the receiver operating characteristic (ROC) except that each data point comes from a different study, not a different threshold [35].”
BackgroundMethodAnalysing and Presenting Results
Macaskill, P., Gatsonis, C., Deeks, J. J., Harbord, R., & Takwoingi, Y. (2010) · Bristol Research (University of Bristol) · Cited by 337
Garfield, S., Clifford, S., Eliasson, L., Barber, N., & Willson, A. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-149 · Cited by 286 · cited 1×
“However, to the best of our knowledge, no systematic review has yet investigated the psychometric properties of the MMAS-8 [27].”
BackgroundArora, S., Peters, A. L., Burner, E., Lam, C. N., & Menchine, M. (2014) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2013.10.012 · Cited by 273
Scale quality: alpha is an inadequate estimate and factor-analytic evidence is needed first of all
Crutzen, R., & Peters, G.-J. Y. (2017) · Health Psychology Review · doi:10.1080/17437199.2015.1124240 · Cited by 253 · cited 1×
“It has been reported that Cronbach’s alpha is not appropriate for internal consistency and reliability of a test [40, 41], but all studies included in this review used it.”
Meta-analysis of coefficient alpha.
Rodriguez, M. C., & Maeda, Y. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.3.306 · Cited by 242 · cited 1×
“Inversely transformed values were then used to calculate the pooled estimate and confidence interval for each index [32].”
MethodMedication Nonadherence: A Diagnosable and Treatable Medical Condition
Marcum, Z. A., Sevick, M. A., & Handler, S. M. (2013) · JAMA · doi:10.1001/jama.2013.4638 · Cited by 228
Park, L. G., Howie-Esquivel, J., Chung, M. L., & Dracup, K. (2014) · Patient Education and Counseling · doi:10.1016/j.pec.2013.10.027 · Cited by 213
Heydari, H., Kamran, A., Ahari, S., Biria, M., & Malepour, A. (2014) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.144914 · Cited by 166 · cited 1×
“Patients with chronic diseases manifesting silent or no symptoms tend to have poor medication adherence [1, 2].”
BackgroundAlGhurair, S. A., Hughes, C. A., Simpson, S. H., & Guirguis, L. M. (2012) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00699.x · Cited by 161 · cited 2×
“One of the most frequently used patient questionnaires for the assessment of medication adherence is the Morisky Medication Adherence Scale (MMAS) [8].”
MethodPatient- and provider-reported adherence
Wagner, J. H., Justice, A. C., Chesney, M. A., Sinclair, G. I., Weissman, S., & Rodriguez‐Barradas, M. C. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00450-4 · Cited by 139 · cited 1×
“Each method has strengths and weakness and one of them could be a reference standard for another method [9, 10].”
MethodMethods Guide for Medical Test Reviews
Chang, S., Matchar, D. B., Smetana, G. W., & Umscheid, C. A. (2012) · Cited by 117
Schueler, S., Schuetz, G. M., & Dewey, M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00018 · Cited by 91 · cited 1×
“Each domain is assessed in terms of risk of bias; the first 3 domains are also assessed in terms of concerns regarding applicability [31].”
BackgroundTabasi, H. K., Madarshahian, F., Nikoo, M. K., Hassanabadi, M., & Mahmoudirad, G. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0113-2 · Cited by 90
Ashur, S. T., Shamsuddin, K., Shah, S. A., Bosseri, S., & Morisky, D. (2015) · Eastern Mediterranean Health Journal · doi:10.26719/2015.21.10.722 · Cited by 89
Self-citationBerry, D., Blonquist, T., Hong, F., Partidge, A., & Halpenny, B. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s91534 · Cited by 78
Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease
Goodhand, J. R., Kamperidis, N., Sirwan, B., Macken, L., Tshuma, N., Koodun, Y., Chowdhury, F. A., Croft, N. M., Direkze, N., Langmead, L., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12476 · Cited by 70 · cited 2×
“On bivariate model analysis, Goodhand et al’s [37] and Ashur et al’s study [38] were potential outliers since their sensitivity and specificity point on SROC were out of 95% predictive region surrounding summary operating point.”
MethodDiBonaventura, M., Wintfeld, N., Huang, J., & Goren, A. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s55550 · Cited by 70
Tandon, S., Chew, M., Eklu-Gadegbeku, C., Shermock, K. M., & Morisky, D. E. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.10.001 · Cited by 65 · cited 1×
“Subgroup analysis of the T2DM group (7 studies) after excluding one study [36] in which Cronbach’s α differed greatly from the others on the forest plot resulted in a pooled estimate of 0.”
MethodSelf-citationGranger, B. B., Ekman, I., Hernandez, A. F., Sawyer, T., Bowers, M. T., DeWald, T. A., Zhao, Y., Levy, J., & Bosworth, H. B. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.01.006 · Cited by 59
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R., Coker‐Schwimmer, E., Grodensky, C. A., Rosen, D. L., Yuen, A., et al. (2012) · PubMed Central · Cited by 57
Evaluation of a Remote Monitoring System for Diabetes Control
Katalenich, B., Shi, L., Liu, S., Shao, H., McDuffie, R., Carpio, G., Thethi, T., & Fonseca, V. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.03.022 · Cited by 56
Alcoba, M., Cuevas, M. J., Perez-Simon, M.-R., Mostaza, J.-L., Ortega, L., de Urbina, J. O., Carro, J. A., Raya, C., Abad, M., & Martin, V. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200306010-00022 · Cited by 45 · cited 1×
“Each method has strengths and weakness and one of them could be a reference standard for another method [9, 10].”
MethodChan, H., & Hassali, M. A. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-0003-1 · Cited by 43 · cited 1×
“Specifically, the MMAS-8 has been used in 12 RCTs investigating acute coronary syndrome [15, 16], diabetes mellitus [17–21], hypertension [22, 23], chronic heart failure [24, 25], and malignant neoplasm [26].”
MethodPatients’ adherence to secondary prevention pharmacotherapy after acute coronary syndromes
Kassab, Y. W., Hassan, Y., Aziz, N. A., Ismail, O., & AbdulRazzaq, H. A. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9735-y · Cited by 43 · cited 1×
“Specifically, the MMAS-8 has been used in 12 RCTs investigating acute coronary syndrome [15, 16], diabetes mellitus [17–21], hypertension [22, 23], chronic heart failure [24, 25], and malignant neoplasm [26].”
MethodGuo, X. H., Ji, L. N., Lu, J. M., Liu, J., Lou, Q. Q., Liu, J., Shen, L., Zhang, M. X., Lv, X. F., & Gu, M. J. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12100 · Cited by 41
Cummings, D. M., Lutes, L., Littlewood, K., DiNatale, E., Hambidge, B., Schulman, K., & Morisky, D. E. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014536532 · Cited by 38
Self-citationVinluan, C. M., Wittman, D., & Morisky, D. E. (2015) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12093 · Cited by 30 · cited 1×
“Specifically, the MMAS-8 has been used in 12 RCTs investigating acute coronary syndrome [15, 16], diabetes mellitus [17–21], hypertension [22, 23], chronic heart failure [24, 25], and malignant neoplasm [26].”
MethodSelf-citationBramlage, P., Ketelhut, R. G., Fronk, E., Wolf, W.-P., Smolnik, R., Zemmrich, C., & Schmieder, R. E. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0188-z · Cited by 27 · cited 1×
“Specifically, the MMAS-8 has been used in 12 RCTs investigating acute coronary syndrome [15, 16], diabetes mellitus [17–21], hypertension [22, 23], chronic heart failure [24, 25], and malignant neoplasm [26].”
MethodParthan, A., Vincze, G., Morisky, D. E., & Khan, Z. M. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.3.325 · Cited by 17 · cited 1×
“Patients with chronic diseases manifesting silent or no symptoms tend to have poor medication adherence [1, 2].”
BackgroundSelf-citationStrategies used by adults to reduce their prescription drug costs.
Cohen, R. A., Kirzinger, W. K., & Gindi, R. M. (2013) · PubMed · Cited by 11
Tepie, M. F., Kempf, C., Letierce, A., Ferreira, I., Kalouche-Khalil, L., Roddam, A., & Guillemin, F. (2013) · Value in Health · doi:10.1016/j.jval.2013.08.1517 · Cited by 1
Cited by
Polypill strategy in secondary cardiovascular prevention
Castellano, J. M., Pocock, S. J., Bhatt, D. L., Quesada, A. J., Owen, R., Fernandez-Ortiz, A., Sanchez, P. L., Marin Ortuño, F., Vazquez Rodriguez, J. M., Domingo-Fernández, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2208275 · Cited by 334
Lee, E. K. P., Poon, P., Yip, B. H. K., Bo, Y., Zhu, M., Yu, C., Ngai, A. C. H., Wong, M. C. S., & Wong, S. Y. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026582 · Cited by 178
Medication nonadherence: health impact, prevalence, correlates and interventions
Stewart, S.-J., Moon, Z., & Horne, R. (2022) · Psychology and Health · doi:10.1080/08870446.2022.2144923 · Cited by 228
“An individuals’ motivation and ability can be influenced by a range of extrinsic factors which facilitate or enable adherent behaviour (Figure 2) such as poor medication distribution services and long waiting times (Hardon et al., 2007), insufficient reimbursement from health insurance plans (Kang et al., 2018), lengt…”
BackgroundMethodInfluentialRuiz-Grosso, P., Cachay, R., de la Flor, A., Schwalb, A., & Ugarte-Gil, C. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227472 · Cited by 134
Kriel, J., & Loos, B. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0267-4 · Cited by 140
Metadata
- Authors
- Moon, S. J., Lee, W.-Y., Hwang, J. S., Hong, Y. P., & Morisky, D. E.
- Affiliations
- Chung-Ang University (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Lee, Weon-Young
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-02
- Volume
- 12
- Issue
- 11
- Pages
- e0187139
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5667769
- OpenAlex
- W2765324371
- Cited by
- 293
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 33 · 2023: 30 · 2022: 23 · 2021: 37 · 2020: 46 · 2019: 35 · 2018: 16 · 2017: 1
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-04-17)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- MMAS-8, medication adherence, adherence screening, psychometric properties, internal consistency, test-retest reliability, sensitivity and specificity, type 2 diabetes, osteoporosis, questionnaire validity
- MeSH terms
- Drug Therapy, Humans, Patient Compliance, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.